Current Ultrasound Technologies and Instrumentation in the Assessment and Monitoring of COVID-19 Positive Patients
- 28 August 2020
- journal article
- research article
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
- Vol. 67 (11), 2230-2240
- https://doi.org/10.1109/tuffc.2020.3020055
Abstract
Since the emergence of the COVID-19 pandemic in December of 2019, clinicians and scientists all over the world have faced overwhelming new challenges that not only threaten their own communities and countries but also the world at large. These challenges have been enormous and debilitating, as the infrastructure of many countries, including developing ones, had little or no resources to deal with the crisis. Even in developed countries, such as Italy, health systems have been so inundated by cases that health care facilities became oversaturated and could not accommodate the unexpected influx of patients to be tested. Initially, resources were focused on testing to identify those who were infected. When it became clear that the virus mainly attacks the lungs by causing parenchymal changes in the form of multifocal pneumonia of different levels of severity, imaging became paramount in the assessment of disease severity, progression, and even response to treatment. As a result, there was a need to establish protocols for imaging of the lungs in these patients. In North America, the focus was on chest X-ray and computed tomography (CT) as these are widely available and accessible at most health facilities. However, in Europe and China, this was not the case, and a cost-effective and relatively fast imaging modality was needed to scan a large number of sick patients promptly. Hence, ultrasound (US) found its way into the hands of Chinese and European physicians and has since become an important imaging modality in those locations. US is a highly versatile, portable, and inexpensive imaging modality that has application across a broad spectrum of conditions and, in this way, is ideally suited to assess the lungs of COVID-19 patients in the intensive care unit (ICU). This bedside test can be done with little to no movement of the patients from the unit that keeps them in their isolated rooms, thereby limiting further exposure to other health personnel. This article presents a basic introduction to COVID-19 and the use of the US for lung imaging. It further provides a high-level overview of the existing US technologies that are driving development in current and potential future US imaging systems for lung, with a specific emphasis on portable and 3-D systems.Funding Information
- National Institutes of Health (R01EY026091, R01EY028662, R01EY030126, NIH P30EY029220)
This publication has 87 references indexed in Scilit:
- Reconfigurable mosaic annular arraysIEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, 2014
- Lung ultrasound for the diagnosis of pneumonia in adults: a systematic review and meta-analysisRespiratory Research, 2014
- Ultrasound elastography for thyroid nodules: recent advancesUltrasonography, 2014
- Lung ultrasound in the critically illAnnals of Intensive Care, 2014
- High-frequency transducers for point-of-care ultrasound applications: what is the optimal frequency range?Internal and Emergency Medicine, 2013
- Ultrasound elastography in liverDiagnostic and Interventional Imaging, 2013
- Core ReviewAnesthesia & Analgesia, 2012
- Point of Care Cardiac Ultrasound Applications in the Emergency Department and Intensive Care Unit - A ReviewCurrent Cardiology Reviews, 2012
- Quantitative shear wave ultrasound elastography: initial experience in solid breast massesBreast Cancer Research, 2010
- Good and bad lipids in the lungNature Medicine, 2010